Health Care: Drugs

Gilead Sciences Inc (GILD: NASDAQ)

$69.94 n/a | n/a%
02/24/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 69.94
52 Week High 103.10
52 Week Low 65.38
Avg. Daily Vol. (Mil) 10.95
Beta (3 year) 1.03
Share Related Items
Mkt Cap (Mil) 91,621.40
Shares Out (Mil) 1,310.00
Float (Mil) 1,351.67
Dividend Information
Yield % 3.00
Annual Dividend 2.08
Payout Ratio 19.00
Financial Strength
Quick Ratio 1.60
Current Ratio 1.90
LT Debt/ Equity 1.56
Total Debt / Equity 1.60
Valuation Ratios
Price Earnings 7.00
Price/Sales 3.01
Price/Book 5.43
Price/Cash Flow 5.60
Per Share Data
Earnings 9.94
Sales 23.20
Book Value 12.88
Cash Flow 12.38
Business Summary
Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.
General Information
333 Lakeside Drive
Foster City, CA 94404
www.gilead.com
Industry : Drugs
Sector: Health Care
Employees: 8000
CEO: Dr. John F. Milligan, Ph
Short Interest
Current Month (Mil) 12.79
Previous Month (Mil) 14.58
Short Interest Ratio (Days) 1.30
Management Effectiveness
Return on Equity 89.40
Return on Assets 26.60
Return on Investments 34.90
Profitability
Gross Margin 90.20
EBIT Margin 61.90
Profit Margin 44.40

Portfolios with GILD

Latest GILD Headlines from TheStreet

More Financial News for GILD

Press Releases for GILD

See All Press Releases

Partner Headlines for GILD

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter